ZFIN ID: ZDB-FIG-191230-1094
Chen et al., 2019 - Pyridoxamine Supplementation Effectively Reverses the Abnormal Phenotypes of Zebrafish Larvae With PNPO Deficiency. Frontiers in pharmacology   10:1086 Full text @ Front Pharmacol
Knockdown Reagent:
Anatomical Term:
Stage: 14-19 somites
Knockdown Reagent:
Observed In:
Stage Range: 14-19 somites to Day 4

Figure 5

The morphological characteristics of zPnpo morphants. Zebrafish embryos of wild-type and transgenic lines injected with zPnpo MO at one- to two-cell stages were grown in embryo water and recorded for embryonic organogenesis and development. Tg(sox10:eGFP) embryos with/without MO injection were imaged at 18 hpf under dissecting light and fluorescent microscopes (AD) and also subjected to WISH analysis with riboprobes pax2.1(EH). Migratory neural crest cells (green fluorescent signals pointed by white arrows) were absent in the closing neural tube (dashed line) of wild-type larvae but remained in that of morphants. Lack or significantly reduced signal for pax2.1 (arrows) were also observed in zPnpo morphants. Both wild-type and zPnpo morphants at 2 dpf were imaged for brain region (IN). A crater-like opening was observed in diencephalic ventricle (arrows) and hindbrain (circled area) of zPnpo morphants. H&E-stained cryosections prepared from the head region [indicated by vertical lines in (N)] of 2-dpf morphants revealed a cavity (*), which was not observed in wild-type larvae (M’ and N’). Tg(cmlc2:eGFP) embryos with/without MO injection were imaged (OR) and video-recorded (S and T, the representative still frames from Suppl. 3–10) under a fluorescent microscope for heart development at 3 dpf. A tubing heart with incorrectly positioned ventricle and atrium were apparent in zPnpo morphants. The somite formation (U and V) and the development of trunk and tail (W and X) were recorded at 18 hpf and 3 dpf, respectively. The somites with chevron shape (solid line in U) can be seen in wild-type embryo. The full view of larvae at the indicated stages was imaged from the lateral view to show the overall morphology and size, which also revealed apparent body curvature for zPnpo morphants (Y). For the images to be taken, embryos/larvae of the indicated stages were removed from the embryo water and placed individually on a drop of methylcellulose for photographing. All images were taken with anterior to the left for lateral view except for brain (AD, EL) and somites (UV) (dorsal) and video recording (S and T) (ventral). WT, wild-type; MO, zPnpo morphants; F, forebrain ventricle; M, midbrain ventricle; H, hindbrain ventricle; nt, neural tube; V, ventricle; A, atrium; WISH, whole-mount in situ hybridization; H&E, hematoxylin and eosin.

Gene Expression Details
Gene Antibody Fish Conditions Stage Anatomy Assay
pax2a nz4Tg standard conditions 14-19 somites midbrain hindbrain boundary ISH
nz4Tg + MO1-pnpo standard conditions 14-19 somites midbrain hindbrain boundary ISH
Antibody Labeling Details No data available
Phenotype Details
Fish Conditions Stage Phenotype
AB + MO1-pnpo standard conditions 14-19 somites somite cuboid, abnormal
Long-pec brain structure, cavities, abnormal
Long-pec neural tube closure arrested, abnormal
Long-pec third ventricle morphology, abnormal
Long-pec third ventricle open, abnormal
Long-pec ventricular system development disrupted, abnormal
Protruding-mouth caudal fin malformed, abnormal
Protruding-mouth trunk curved ventral, abnormal
Protruding-mouth trunk malformed, abnormal
Protruding-mouth whole organism decreased size, abnormal
Day 4 whole organism decreased size, abnormal
hn1Tg + MO1-pnpo standard conditions Protruding-mouth atrium position, abnormal
Protruding-mouth cardiac ventricle position, abnormal
Protruding-mouth heart linear, abnormal
Protruding-mouth heart looping disrupted, abnormal
nz4Tg + MO1-pnpo standard conditions 14-19 somites midbrain hindbrain boundary pax2a expression decreased amount, abnormal
14-19 somites neural crest cell migration disrupted, abnormal
14-19 somites neural crest cell mislocalised, abnormal
ZFIN wishes to thank the journal Frontiers in pharmacology for permission to reproduce figures from this article. Please note that this material may be protected by copyright. Full text @ Front Pharmacol